Dr. Colvin is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Colvin's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFELLOWSHIP
  • Duke University School of Medicine
    Duke University School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1998 - 2021
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Abstracts/Posters

  • Northstar-3: Interim Results from a Phase 3 Study Evaluating Lentiglobin Gene Therapy in Patients with Transfusion-Dependent _-Thalassemia and Either a _0 or IVS-I-110...
    Richard A. Colvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Northstar-2: Updated Safety and Efficacy Analysis of Lentiglobin Gene Therapy in Patients with Transfusion-Dependent _-Thalassemia and Non-_0/_0 Genotypes
    Richard A. Colvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Grant Support

  • Signaling Through Chemokine Receptor CXCR3National Institute Of Allergy And Infectious Diseases2001–2003

Hospital Affiliations